CN105816907A - Medical gel and preparation method for utilizing medical gel to prepare gel wet-patch - Google Patents
Medical gel and preparation method for utilizing medical gel to prepare gel wet-patch Download PDFInfo
- Publication number
- CN105816907A CN105816907A CN201610241091.7A CN201610241091A CN105816907A CN 105816907 A CN105816907 A CN 105816907A CN 201610241091 A CN201610241091 A CN 201610241091A CN 105816907 A CN105816907 A CN 105816907A
- Authority
- CN
- China
- Prior art keywords
- gel
- purified water
- medical
- magnesium sulfate
- medical gel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0023—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0004—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0014—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0019—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0057—Ingredients of undetermined constitution or reaction products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/008—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
- A61L2300/104—Silver, e.g. silver sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
- A61L2300/208—Quaternary ammonium compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/30—Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Materials Engineering (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Botany (AREA)
- Zoology (AREA)
- Dispersion Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses medical gel comprising the following components in weight ratio: 10%-60% of magnesium sulfate, 0.01%-5% of plant extracts, 0.5%-15% of glycerol, 0.1%-5% of ethyl alcohol, 0.5%-20% of a hydrophilic polymer material, 0.5%-15% of PEG40-hydrogenated castor oil, 0.001%-5% of an antibacterial agent and the balance of purified water; the plant extracts are plant extracts with functions of promoting penetration, inhibiting bacteria, diminishing inflammation and relieving pain. The invention further discloses a gel wet-patch prepared by utilizing the medical gel, and a preparation method thereof. The medical gel provided by the invention has the functions of decreasing the level of dropsy, diminishing inflammation, relieving pain, inhibiting bacteria, protecting skin and the like, and is non-irritative to a human body; the use is safe, the medical gel takes effect quickly, and the curative effect is good.
Description
Technical field
The present invention relates to a kind of medical gel, particularly relate to one and utilize medical gel preparation to have elimination edema, control
Treat the gel wet application of the function such as phlebitis and soft tissue injury.
Background technology
50% magnesium sulfate is hyperosmotic solution, the moisture in available concentration difference absorptive tissue, plays the effect of detumescence.Simultaneously
Magnesium ion can suppress Calcium-ion absorption, thus suppresses the contraction of vascular smooth muscle, improves the microcirculation of edematous site, interstitial fluid
Backflow blood vessel, thus alleviate local and ooze out.Owing to blood circulation is improved, strengthen the phagocytosis of metabolism and leukocyte
Function, reaches the purpose of infection and antiinflammatory.
Clinically, conventional 30%-50% Adlerika soaks gauze or towel spreads on affected part, and the method is in operation
Need to add at set intervals Adlerika, and Adlerika adhesional wetting sheet or patient's clothing the most often occur
The situation of thing, makes troubles to patient and medical personnel.It is wet that existing magnesium sulfate wet application many employings non-woven fabrics soaks magnesium sulfate
Deposited fluid-tight is loaded in packaging bag, during use, wet application is spread on affected part, wraps up with preservative film, prevents moisture evaporation or liquid stream
Go out to bedew sheet or medicated clothing.Patient's illing skin is in the case of airproof, and the long period contacts high concentration salt solutions, causes
Skin immune function controlling declines, susceptible or cause blister erythema etc..
Patent (CN 101485680 A) discloses a kind of compound magnesium sulphate catablasm and preparation method thereof.In the program,
Primary medicinal component magnesium sulfate content is far below clinical typical concentrations, and to make cataplasma be solid-state, and medicine is risen slow releasing function,
Though addition Mentholum is as permeation enhancers, but not as good as 50% magnesium sulfate dressing liquid instant effect.Lidocaine hydrochloride clinic is mainly used in
Local anesthetic, has analgesic effect.Content and the clinical data of this patent with reference to lidocaine hydrochloride and magnesium sulfate, it is known that
Compound magnesium sulphate catablasm has preferable analgesic effect, and its treatment edema and phlebitic effect are relatively weak.
Patent (CN 104107190 A) discloses a kind of disposable wet application and preparation method thereof, its soak liquid exist with
Lower deficiency: one, mannitol intravenous administration is administered, reaches dehydration by osmotic diuresis, and external application can not reach dehydration
Effect.Two, dexamethasone is glucocorticoid medicine, is mainly used in dermatitis, eczema, and human body is had relatively first mate to make by life-time service
With.
Summary of the invention
Because the drawbacks described above of prior art, the technical problem to be solved be to provide a kind of medical gel and
The wet application prepared based on this gel, this wet application have the effect such as edema, antiinflammatory, pain relieving, antibacterial, skin protection and to human body without
Zest, uses safety, rapid-action, good effect.
Present invention also offers the preparation method of above-mentioned wet application.
For achieving the above object, the invention provides a kind of medical gel, be made up of following components and weight ratio thereof: 10%-
60% magnesium sulfate, 0.01%-5% plant extract, 0.5%-15% glycerol, 0.1%-5% ethanol, 0.5%-20% hydrophilicity macromolecule material
Material, 0.5%-15%PEG40-castor oil hydrogenated, 0.001%-5% antibacterial, surplus are purified water.
Described plant extract is to have saturating, antibacterial, the antiinflammatory of rush, the plant extract of analgesic effect, can be to have
The material of transdermal enhancer effect, such as Oleum menthae, Borneolum Syntheticum etc., it is also possible to has antibacterial, antiinflammatory, pain relieving or goes edema effect
Plant extract, as Cortex Moutan, Rhizoma Curcumae Longae, Folium eucalypti globueli (Eucalyptus globulus Labill.), Camellia sinensis, Herba thymi vulgaris, Calendula officinalis, Radix Glycyrrhizae, Radix Et Rhizoma Rhei, Rhizoma Chuanxiong, Herba Portulacae, Aloe,
Radix Hamamelidis Mollis, Flos Chrysanthemi Indici, Flos Lonicerae, Herba Taraxaci, Herba Schizonepetae, lavandula angustifolia, Flos Caryophylli, Herba Rosmarini Officinalis, Radix Sophorae Flavescentis, Fructus Sapindi Mukouossi, Radix Zanthoxyli, Semen daturae,
The Radix Stemonae, Poria, Flos Matricariae chamomillae, Radix Scutellariae, Rhizoma Coptidis, rutin, Salvia japonica Thunb., Rhizoma Polygoni Cuspidati, Semen Myristicae, Saw Palmetto P.E etc..
Described antibacterial can be inorganic antiseptic (such as: silver ion etc.), organic antibacterial agent (such as: quaternary ammonium salt etc.), sky
So antibacterial (such as: chitosan etc.) or be have plant extract (such as the clove oil etc.) one therein of bacteriostatic activity or its
Meaning combination.Concrete, described antibacterial is silver ion, quaternary ammonium salt, biguanides, sorbic acid and salt thereof, parabens, shell
The one therein such as polysaccharide or its combination in any, or be Efficient antibacterial, anticorrosion plant extract.
Described hydrophilic high molecular material be sodium carboxymethyl cellulose, chitosan, gelatin, agar, carboxy-propyl cellulose,
Xanthan gum, carrageenan, locust bean gum, guar gum, sodium alginate, pectin, arabic gum and starch and derivant, hydroxy ethyl fiber
One therein or its combination in any such as element, polyvinyl alcohol, polyacrylic acid, polyvinylpyrrolidone.
A kind of gel wet application, including medical gel and medical carrier, described medical carrier be non-woven fabrics, absorbent cotton,
Gauze, sponge, absorbent paper is therein a kind of or its combination in any or the antiseptic dressing prepared for above-mentioned material.
Described carrier includes two sides, is coated with breathing waterproof film away from the one side contacted with affected part;Described is ventilative anti-
Moisture film uses the material of polypropylene type, polyethylene kind, polyurethanes one of which or its any combination to make.So can be to carrier
In medical gel play and reduce evaporation and other fixing material laminating etc. causes the effect of loss.
The preparation method of a kind of gel wet application, comprises the following steps:
(1) purified water is boiled 3-10 minute, be cooled to room temperature (now-making-now-using);
(2) take 125g-500g magnesium sulfate, add 500ml purified water and dissolve;
(3) 30ml-50ml70% ethanol, 1ml-5mlPEG40-castor oil hydrogenated and 5ml-150ml glycerol are mixed, add 1ml-
5ml plants essential oil dissolves;
(4) take 10g-200g hydrophilic high molecular material and 0.1g-50g anti-biotic material, add 300ml purified water, mix well;
(5) by (2), (3), (4) three kinds of solution mixings, it is settled to 1000ml by purified water;
(6) take out after soak medical carrier at least half an hour of above-mentioned preparation.
The invention has the beneficial effects as follows: present invention application hydrophilic high molecular material does Adlerika carrier, can be effective
Water conservation and there is preferable breathability.Plant extract is added, as the transdermal enhancer such as Oleum menthae, Borneolum Syntheticum can promote in gel
Drug Percutaneous Absorption, makes drug effect faster.Additionally, Oleum menthae separately has the effects such as antibacterial, antiinflammatory, pain relieving and slight local anaesthesia.
Borneolum Syntheticum separately has the effects such as antibacterial, antiinflammatory, detumescence, pain relieving.Additionally add and there is skin care effect or antiinflammatory, antibacterial, pain relieving, detumescence
The plant extract of effect, can protect the skin from again injuring.Radix Glycyrrhizae extract has antibacterial, antiinflammatory, antiallergic, solution carbuncle
The effects such as sore and reduction drug toxicity.Have plant extract antibacterial, antiinflammation also have Herba Portulacae, Aloe, Radix Hamamelidis Mollis,
Flos Chrysanthemi Indici, Flos Lonicerae, Herba Taraxaci, Herba Schizonepetae, Calendula officinalis extract.Adding antibacterial in gel, not only to make gel have inherent antibacterial
Property, enhanced stability, and in use can suppress skin surface microbial growth.
The selected plant extract of gel wet application of the present invention, and add antibacterial, skin care ingredient, non-stimulated to human body
Property, use safety, rapid-action, good effect.
Detailed description of the invention
Below in conjunction with embodiment, the invention will be further described:
Embodiment one:
A kind of medical gel, is made up of following components and weight ratio thereof: 60% magnesium sulfate, 3% plant extract, 2% glycerol, 3% second
Alcohol, 10% hydrophilic high molecular material, 4%PEG40-castor oil hydrogenated, 0.03% silver ion, surplus are purified water;
Embodiment two:
A kind of medical gel, is made up of following components and weight ratio thereof: 30% magnesium sulfate, 0.5% plant extract, 12% glycerol,
0.5% ethanol, 4% hydrophilic high molecular material, 2%PEG40-castor oil hydrogenated, 5% chitosan, surplus are purified water;
Embodiment three:
A kind of medical gel, is made up of following components and weight ratio thereof: 12.5% magnesium sulfate, 4% plant extract, 6% glycerol, 2%
Ethanol, 16% hydrophilic high molecular material, 5%PEG40-castor oil hydrogenated, 0.1% quaternary ammonium salt, surplus are purified water;
Embodiment four:
A kind of medical gel, is made up of following components and weight ratio thereof: 12.5%-60% magnesium sulfate, 0.01%-2% Oleum menthae,
0.01%-1% paeonol, 0.01%-1% lonicera oil, 10%-20% sodium carboxymethyl cellulose, 1%-5%PEG40-castor oil hydrogenated,
1%-5% chitosan, 0.5%-15% glycerol, 0.1%-3% ethanol, surplus purified water.
Embodiment five:
A kind of medical gel, is made up of following components and weight ratio thereof: 60% magnesium sulfate, 0.5% Oleum menthae, 0.5% paeonol,
0.5% lonicera oil, 10%-20% sodium carboxymethyl cellulose, 1%-5%PEG40-castor oil hydrogenated, 1%-5% chitosan, 10% glycerol,
3% ethanol, surplus purified water.
Embodiment six:
A kind of medical gel, is made up of following components and weight ratio thereof: 12.5%-60% magnesium sulfate, 0.01%-3% Borneolum Syntheticum, 0.01%-
5% aloe, 5%-10% sodium carboxymethyl cellulose, 1%-5%PEG40-castor oil hydrogenated, 1%-5% gelatin, 1%-15% glycerol,
0.1%-3% ethanol, 0.005%-0.04% silver ion, surplus purified water.
Embodiment seven:
A kind of medical gel, is made up of following components and weight ratio thereof: 12.5%-60% magnesium sulfate, 0.01%-2% Oleum menthae,
0.01%-5% Oleum lavandula angustifolia, 0.5%-1.5% sodium carboxymethyl cellulose, 1%-5%PEG40-castor oil hydrogenated, 1%-15% glycerol,
0.1%-3% ethanol, 0.01%-0.2% quaternary ammonium salt, surplus purified water.
Embodiment eight:
A kind of medical gel, is made up of following components and weight ratio thereof: 10%-60% magnesium sulfate, 0.01%-5% plant extract,
0.5%-15% glycerol, 0.1%-5% ethanol, 0.5%-20% sodium carboxymethyl cellulose, 0.5%-15%PEG40-castor oil hydrogenated, 1%-
5% chitosan, 0.01%-0.2% quaternary ammonium salt, surplus are purified water.Described gel adds chitosan and quaternary ammonium salt, acts primarily as and kill
Bacterium effect.Additionally, the addition of chitosan improves the moisture retention of gel.
Embodiment nine:
The preparation method of a kind of gel wet application, comprises the following steps:
(1) purified water is boiled 3-10 minute, be cooled to room temperature (now-making-now-using);
(2) take 125g-500g magnesium sulfate, add 500ml purified water and dissolve;
(3) 30ml-50ml70% ethanol, 1ml-10mlPEG40-castor oil hydrogenated and 5ml-150ml glycerol are mixed, add 1g-
30g Borneolum Syntheticum and 1ml-20ml aloe dissolve;
(4) take 10g-200g sodium carboxymethyl cellulose, mix with 10g-50g chitosan or 0.1g-2g quaternary ammonium salt, add 300ml
Purified water, mixes well;
(5) by (2), (3), (4) two kinds of solution mixings;It is settled to 1000ml by purified water;
(6) take out after soak medical carrier half an hour of above-mentioned preparation.
Embodiment ten:
The preparation method of a kind of gel wet application, comprises the following steps:
(1) purified water is boiled 5 minutes, be cooled to room temperature (now-making-now-using);
(2) take 500g magnesium sulfate, add 500ml purified water heating for dissolving;
(3) 5ml70% ethanol, 10ml glycerol and 8mlPEG40-castor oil hydrogenated are mixed, add 1ml Oleum menthae and 5ml smokes clothing
Grass oil dissolves.
(4) take 20g sodium carboxymethyl cellulose, mix with 50g chitosan, add 300ml purified water and mix well;
(5) by (2), (3), (4) three kinds of solution mixings, it is settled to 1000ml by purified water;
(6) take out after soak medical carrier half an hour of above-mentioned preparation.
Embodiment 11:
The preparation method of a kind of gel wet application, comprises the following steps:
(1) purified water is boiled 5 minutes, be cooled to room temperature (now-making-now-using);
(2) take 500g magnesium sulfate, add 500ml purified water heating for dissolving;
(3) 5ml95% ethanol, 10ml glycerol and 8mlPEG40-castor oil hydrogenated are mixed, add 1g Borneolum Syntheticum and 5ml Aloe oil soluble
Solve.
(4) take 20g sodium carboxymethyl cellulose, mix with 1.5g quaternary ammonium salt, add 300ml purified water and mix well;
(5) by (2), (3), (4) three kinds of solution mixings, it is settled to 1000ml by purified water;
(6) take out after soak medical carrier half an hour of above-mentioned preparation.
Embodiment 12:
The preparation method of a kind of gel wet application, comprises the following steps:
(1) purified water is boiled 5 minutes, be cooled to room temperature (now-making-now-using);
(2) take 330g magnesium sulfate, add 500ml purified water heating for dissolving, after being cooled to room temperature, add 0.45g silver nitrate and make
It dissolves;
(3) 5ml70% ethanol, 10ml glycerol and 8mlPEG40-castor oil hydrogenated are mixed, add 1ml Oleum menthae and 5ml Aloe
Oil dissolves.
(4) take 100g sodium carboxymethyl cellulose, mix with 10g gelatin, add 300ml purified water and mix well;
(5) by (2), (3), (4) three kinds of solution mixings, it is settled to 1000ml by purified water;
(6) take out after soak medical carrier half an hour of above-mentioned preparation.
Compliance test result
By rabbit auricular vein total length preserved skin, intravenous injection 20% mannitol, three times a day, continuous three days, set up scleroma type phlebitis
Model.
4 groups are divided at random, often group 6 by successful for modeling laboratory animal.Matched group: 50% magnesium sulfate room temperature soak treatment;Real
Test group: embodiment four room temperature soak is treated.Soak treats every day 4 times, each 45min.Soak time 3d altogether.
Soak was drawn materials in right side auricular vein after 72 hours, carried out observing under optical microscope after staining pathologic section,
Observation item is: extent of hemorrhage, cell infiltration degree, edema degree around blood vessel wall damaged condition, blood vessel, to observation item
Setting up level index, degree is the highest, and score is the highest: with (-) it is 0 point, (+) it is 1 point, (++) is 2 points
, (+++) is 3 points.
Carry out variance analysis after test data is added up, find experimental group indices be significantly better than that matched group (p <
0.05) the gel wet application that, experimental group uses has obviously advantage to phlebitis curative effect.
The preferred embodiment of the present invention described in detail above.Should be appreciated that those of ordinary skill in the art without
Need creative work just can make many modifications and variations according to the design of the present invention.Therefore, all technology in the art
Personnel are available by logical analysis, reasoning, or a limited experiment the most on the basis of existing technology
Technical scheme, all should be in the protection domain being defined in the patent claims.
Claims (10)
1. a medical gel, it is characterised in that be made up of following components and weight ratio thereof: 10%-60% magnesium sulfate, 0.01%-5%
Plant extract, 0.5%-15% glycerol, 0.1%-5% ethanol, 0.5%-20% hydrophilic high molecular material, 0.001%-5% antibacterial,
0.5%-15%PEG40-castor oil hydrogenated, surplus are purified water;Described plant extract for have rush thoroughly or antiinflammatory, pain relieving,
Antibacterial, the plant extract of skin care effect.
2. medical gel as claimed in claim 1 a kind of, it is characterised in that described plant extract is Herba Menthae, Borneolum Syntheticum, male
Cortex Moutan, Rhizoma Curcumae Longae, Folium eucalypti globueli (Eucalyptus globulus Labill.), Camellia sinensis, Herba thymi vulgaris, Calendula officinalis, Radix Glycyrrhizae, Radix Et Rhizoma Rhei, Rhizoma Chuanxiong, Herba Portulacae, Aloe, Radix Hamamelidis Mollis, Flos Chrysanthemi Indici, gold
Flos Lonicerae, Herba Taraxaci, Herba Schizonepetae, rutin, Salvia japonica Thunb., Rhizoma Polygoni Cuspidati, Semen Myristicae, sabal, lavandula angustifolia, Flos Caryophylli, Fructus Sapindi Mukouossi, Radix Zanthoxyli, top
Eggplant, the Radix Stemonae, Poria, Flos Matricariae chamomillae, Radix Scutellariae, Rhizoma Coptidis, Herba Rosmarini Officinalis, the extract one therein such as Radix Sophorae Flavescentis, Cortex cinnamomi japonici (Ramulus Cinnamomi), Fructus Piperis, Bulbus Allii or
Its combination in any;
Described antibacterial be silver ion, quaternary ammonium salt, biguanides, sorbic acid and salt thereof, parabens, chitosan etc. wherein
One or its combination in any, or be Efficient antibacterial, anticorrosion plant extract;
Described hydrophilic high molecular material is sodium carboxymethyl cellulose, chitosan, gelatin, agar, carboxy-propyl cellulose, xanthan
Glue, carrageenan, locust bean gum, guar gum, sodium alginate, pectin, arabic gum and starch and derivant thereof, hydroxyethyl cellulose,
Polyvinyl alcohol, polyacrylic acid, polyvinylpyrrolidone one therein or its combination in any.
3. a kind of medical gel as claimed in claim 1 or 2, it is characterised in that be made up of following components and weight ratio thereof:
12.5% magnesium sulfate, 4% plant extract, 6% glycerol, 2% ethanol, 16% hydrophilic high molecular material, 8%PEG40-hydrogenated castor
Oil, 0.1% quaternary ammonium salt, surplus are purified water.
4. a kind of medical gel as claimed in claim 1 or 2, it is characterised in that be made up of following components and weight ratio thereof:
12.5%-60% magnesium sulfate, 0.01%-2% Oleum menthae, 0.01%-1% paeonol, 0.01%-1% lonicera oil, 10%-20% carboxymethyl
Sodium cellulosate, 1%-5%PEG40-castor oil hydrogenated, 1%-5% chitosan, 0.5%-15% glycerol, 0.1%-5% ethanol, surplus purification
Water.
5. a kind of medical gel as claimed in claim 1 or 2, it is characterised in that be made up of following components and weight ratio thereof:
12.5%-60% magnesium sulfate, 0.01%-3% Borneolum Syntheticum, 0.01%-5% aloe, 5%-10% sodium carboxymethyl cellulose, 1%-5% gelatin,
1%-5%PEG40-castor oil hydrogenated, 0.5%-15% glycerol, 0.1%-5% ethanol, 0.01%-0.2% quaternary ammonium salt, surplus purified water.
6. a kind of medical gel as claimed in claim 1 or 2, it is characterised in that be made up of following components and weight ratio thereof:
12.5%-60% magnesium sulfate, 0.01%-2% Oleum menthae, 0.01%-5% Oleum lavandula angustifolia, 0.5%-1.5% sodium carboxymethyl cellulose, 1%-5%
PEG40-castor oil hydrogenated, 0.5%-15% glycerol, 0.1%-5% ethanol, 0.005%-0.04% silver ion, surplus purified water.
7. a kind of medical gel as claimed in claim 1 or 2, it is characterised in that be made up of following components and weight ratio thereof:
10%-60% magnesium sulfate, 0.01%-5% plant extract, 0.5%-15% glycerol, 0.1%-5% ethanol, 0.5%-20% carboxymethyl cellulose
Element sodium, 1%-5%PEG40-castor oil hydrogenated, surplus are purified water.
8. a medical gel wet application, it is characterised in that include the medical gel described in claim 1-7 and medical carrier,
Described medical carrier is non-woven fabrics, absorbent cotton, gauze, sponge, absorbent paper one therein or its combination in any or is above-mentioned
Antiseptic dressing prepared by material.
9. gel wet application as claimed in claim 8 a kind of, is characterized in that, described carrier includes two sides, away from affected part
The one side of contact is coated with breathing waterproof film;Described breathing waterproof film uses polypropylene type, polyethylene kind, polyurethanes wherein
A kind of or its any combination material makes.
10. prepare the preparation method of gel wet application described in claim 8-9 for one kind, it is characterised in that comprise the following steps:
(1) purified water is boiled 3-10 minute, be cooled to room temperature;
(2) take 125g-500g magnesium sulfate, add 500ml purified water and dissolve;
(3) 30ml-50ml70% ethanol, 1ml-5mlPEG40-castor oil hydrogenated and 5ml-150ml glycerol are mixed, add 1ml-
50ml plants essential oil dissolves;
(4) take 10g-200g hydrophilic high molecular material and 0.1g-50g anti-biotic material, add 300ml purified water, mix well;
(5) by (2), (3), (4) three kinds of solution mixings, it is settled to 1000ml by purified water;
(6) take out after soak medical carrier at least half an hour of above-mentioned preparation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610241091.7A CN105816907A (en) | 2016-04-19 | 2016-04-19 | Medical gel and preparation method for utilizing medical gel to prepare gel wet-patch |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610241091.7A CN105816907A (en) | 2016-04-19 | 2016-04-19 | Medical gel and preparation method for utilizing medical gel to prepare gel wet-patch |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105816907A true CN105816907A (en) | 2016-08-03 |
Family
ID=56526165
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610241091.7A Pending CN105816907A (en) | 2016-04-19 | 2016-04-19 | Medical gel and preparation method for utilizing medical gel to prepare gel wet-patch |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105816907A (en) |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106138190A (en) * | 2016-08-08 | 2016-11-23 | 林湧博 | A kind of external-use gel preparation, preparation method and its usage |
CN106729939A (en) * | 2016-12-29 | 2017-05-31 | 河南亚都实业有限公司 | A kind of dressing for treating bedsore |
CN107496972A (en) * | 2017-09-20 | 2017-12-22 | 重庆理工大学 | A kind of moist dressing and preparation method thereof that prevents adhesion for promoting burn wound healing |
CN107970488A (en) * | 2018-01-08 | 2018-05-01 | 广州润虹医药科技股份有限公司 | A kind of chitin quarternary ammonium salt aquagel antiseptic dressing and preparation method thereof |
CN108578749A (en) * | 2018-07-11 | 2018-09-28 | 淮阴工学院 | A kind of medical compound pomelo-pectin sponge dressing and its preparation method and application of medicine-carried sustained release |
CN108992704A (en) * | 2018-08-20 | 2018-12-14 | 丹东欣时代生物医药科技有限公司 | A kind of liquid adhesive bandage and preparation method thereof |
CN109045344A (en) * | 2018-07-05 | 2018-12-21 | 安徽玉然经编科技有限公司 | A kind of medical bandage antiallergy pressure-sensitive adhesive and preparation method thereof |
CN109512851A (en) * | 2018-12-28 | 2019-03-26 | 惠州卫生职业技术学院 | Medical antibacterial midwifery gel of one kind and preparation method thereof |
CN109793918A (en) * | 2018-12-29 | 2019-05-24 | 中国人民解放军总医院 | It can promote the plant society dressing of extensive wound hair follicle regeneration |
CN110393825A (en) * | 2018-04-25 | 2019-11-01 | 北京为纳百川商贸有限公司 | A kind of body lotion |
CN111494259A (en) * | 2020-04-23 | 2020-08-07 | 苦蒲丹(山东)中药科技有限公司 | Herbal antibacterial disinfectant |
CN111607970A (en) * | 2020-04-23 | 2020-09-01 | 苦蒲丹(山东)中药科技有限公司 | Preparation method of traditional Chinese medicine antibacterial mask material |
CN111991613A (en) * | 2020-09-28 | 2020-11-27 | 青岛鸿蒙草本医疗科技有限公司 | Liquid dressing and preparation method thereof |
WO2021017055A1 (en) * | 2019-07-30 | 2021-02-04 | 珠海水丝新材料有限公司 | Water-absorbing membrane material and preparation method therefor |
CN112868678A (en) * | 2021-01-14 | 2021-06-01 | 广东迪美新材料科技有限公司 | Plant antibacterial mite-killing agent, preparation method thereof and daily necessities containing plant antibacterial mite-killing agent |
WO2021129617A3 (en) * | 2019-12-26 | 2021-10-07 | 华熙生物科技股份有限公司 | Topical composition for preventing, alleviating, or treating skin allergies, and use therefor |
CN113730641A (en) * | 2021-09-28 | 2021-12-03 | 珠海金标生物科技有限公司 | Slow-release antibacterial dressing and preparation method thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09315964A (en) * | 1996-05-27 | 1997-12-09 | Chinhin Boku | Cataplasm for stiff shoulder and frozen shoulder syndrome |
CN1679520A (en) * | 2005-01-11 | 2005-10-12 | 中国人民解放军第二军医大学 | Compound analgesic agent |
CN101485680A (en) * | 2009-03-02 | 2009-07-22 | 贾国平 | Compound magnesium sulphate catablasm and preparation method thereof |
CN104069539A (en) * | 2014-07-23 | 2014-10-01 | 桑洪义 | Medical hypertonic colloid dressing and preparation method thereof |
CN104107190A (en) * | 2014-07-22 | 2014-10-22 | 陈伟权 | Disposable wet plaster and preparation method thereof |
-
2016
- 2016-04-19 CN CN201610241091.7A patent/CN105816907A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09315964A (en) * | 1996-05-27 | 1997-12-09 | Chinhin Boku | Cataplasm for stiff shoulder and frozen shoulder syndrome |
CN1679520A (en) * | 2005-01-11 | 2005-10-12 | 中国人民解放军第二军医大学 | Compound analgesic agent |
CN101485680A (en) * | 2009-03-02 | 2009-07-22 | 贾国平 | Compound magnesium sulphate catablasm and preparation method thereof |
CN104107190A (en) * | 2014-07-22 | 2014-10-22 | 陈伟权 | Disposable wet plaster and preparation method thereof |
CN104069539A (en) * | 2014-07-23 | 2014-10-01 | 桑洪义 | Medical hypertonic colloid dressing and preparation method thereof |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106138190A (en) * | 2016-08-08 | 2016-11-23 | 林湧博 | A kind of external-use gel preparation, preparation method and its usage |
CN106138190B (en) * | 2016-08-08 | 2020-03-31 | 浙江奕箔生物科技有限公司 | External gel preparation, preparation method and application thereof |
CN106729939A (en) * | 2016-12-29 | 2017-05-31 | 河南亚都实业有限公司 | A kind of dressing for treating bedsore |
CN107496972A (en) * | 2017-09-20 | 2017-12-22 | 重庆理工大学 | A kind of moist dressing and preparation method thereof that prevents adhesion for promoting burn wound healing |
CN107970488A (en) * | 2018-01-08 | 2018-05-01 | 广州润虹医药科技股份有限公司 | A kind of chitin quarternary ammonium salt aquagel antiseptic dressing and preparation method thereof |
CN110393825A (en) * | 2018-04-25 | 2019-11-01 | 北京为纳百川商贸有限公司 | A kind of body lotion |
CN109045344A (en) * | 2018-07-05 | 2018-12-21 | 安徽玉然经编科技有限公司 | A kind of medical bandage antiallergy pressure-sensitive adhesive and preparation method thereof |
CN108578749A (en) * | 2018-07-11 | 2018-09-28 | 淮阴工学院 | A kind of medical compound pomelo-pectin sponge dressing and its preparation method and application of medicine-carried sustained release |
CN108992704A (en) * | 2018-08-20 | 2018-12-14 | 丹东欣时代生物医药科技有限公司 | A kind of liquid adhesive bandage and preparation method thereof |
CN109512851B (en) * | 2018-12-28 | 2021-06-08 | 惠州卫生职业技术学院 | Preparation method of medical antibacterial midwifery gel |
CN109512851A (en) * | 2018-12-28 | 2019-03-26 | 惠州卫生职业技术学院 | Medical antibacterial midwifery gel of one kind and preparation method thereof |
CN109793918A (en) * | 2018-12-29 | 2019-05-24 | 中国人民解放军总医院 | It can promote the plant society dressing of extensive wound hair follicle regeneration |
WO2021017055A1 (en) * | 2019-07-30 | 2021-02-04 | 珠海水丝新材料有限公司 | Water-absorbing membrane material and preparation method therefor |
WO2021129617A3 (en) * | 2019-12-26 | 2021-10-07 | 华熙生物科技股份有限公司 | Topical composition for preventing, alleviating, or treating skin allergies, and use therefor |
CN111607970A (en) * | 2020-04-23 | 2020-09-01 | 苦蒲丹(山东)中药科技有限公司 | Preparation method of traditional Chinese medicine antibacterial mask material |
CN111494259A (en) * | 2020-04-23 | 2020-08-07 | 苦蒲丹(山东)中药科技有限公司 | Herbal antibacterial disinfectant |
CN111991613A (en) * | 2020-09-28 | 2020-11-27 | 青岛鸿蒙草本医疗科技有限公司 | Liquid dressing and preparation method thereof |
CN112868678A (en) * | 2021-01-14 | 2021-06-01 | 广东迪美新材料科技有限公司 | Plant antibacterial mite-killing agent, preparation method thereof and daily necessities containing plant antibacterial mite-killing agent |
CN113730641A (en) * | 2021-09-28 | 2021-12-03 | 珠海金标生物科技有限公司 | Slow-release antibacterial dressing and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105816907A (en) | Medical gel and preparation method for utilizing medical gel to prepare gel wet-patch | |
CN105854072A (en) | Medical gel and method for preparing medical treatment gel paster for external use through medical gel | |
CN101167847B (en) | Traditional Chinese medicinal white spirit preparation for effectively treating skin disease | |
CN105833279B (en) | External-use medicine composition for treating various wound surfaces of skin and preparation method thereof | |
CN101553241A (en) | Herbal formulation for wound healing | |
CN106177408A (en) | A kind of resisting skin allergy Chinese medicine composition, Chinese medicine preparation, facial film, preparation method | |
CN102429986B (en) | Traditional Chinese ointment for treating burn and scald and preparation method thereof | |
CN101485727A (en) | External-use tinctura for treating chilblain | |
CN101244185A (en) | Chinese medicinal herb composition for treating skin disease and cloth containing the combination | |
CN102178810B (en) | Chinese medicinal paste film for treating skin ulcer and preparation method thereof | |
CN102451134A (en) | Washing-free bath dew capable of curing cold and preparation method thereof | |
CN102178811B (en) | Medicament for treating skin ulcer and preparation method thereof | |
CN100462098C (en) | Chinese medicine ointment for treating bone disease and its preparing method | |
CN101658590A (en) | Chinese medicinal paste having effect of activating blood circulation and reducing swelling | |
KR20060033070A (en) | Hip-bath compositions for treatment of herorrhoids or gynecological diseases, and hip-bath bag containing it | |
CN112156225A (en) | Chitosan or and algal polysaccharide composite biological matrix liquid dressing gel preparation and preparation method thereof | |
CN105267516A (en) | Plaster for skin surface local anesthesia | |
CN100339122C (en) | Ointment for treating chronic osteitis | |
CN1907483A (en) | Navel-applying medicine for treating menorrhalgia and its preparation method | |
CN102379952B (en) | Traditional Chinese medicine cataplasm for preventing and treating phlebitis | |
CN108578551A (en) | Treat the Chinese medicine film and preparation method thereof of foot rot | |
CN108283670A (en) | A kind of pharmaceutical composition and preparation method thereof for treating burn and scald | |
CN108853293B (en) | Compound essential oil for treating hemorrhoids and preparation method and use method thereof | |
CN104398796B (en) | One kind oozes out dermatoses Wet-dressing agent and preparation method thereof | |
CN101288760B (en) | Externally-used drug for treating appendicitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160803 |
|
RJ01 | Rejection of invention patent application after publication |